Evidence map›Paper›PMID 38715081›Full record

ArticleVeterinary research2024

The haemagglutinin-neuraminidase protein of velogenic Newcastle disease virus enhances viral infection through NF-κB-mediated programmed cell death.

Xiaolong Lu, Tiansong Zhan, Qiwen Zhou, Wenhao Yang, Kaituo Liu, Yu Chen, Ruyi Gao, Jiao Hu, Min Gu, Shunlin Hu and 4 more

Abstract read
In one paragraph

Article in Veterinary research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Xiaolong LuAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Tiansong ZhanAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Qiwen ZhouAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Wenhao YangAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Kaituo LiuAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Yu ChenAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Ruyi GaoAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Jiao HuAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Min GuAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Shunlin HuAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Xin-An JiaoAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Xiaoquan WangAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China.
Xiufan LiuAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China. xfliu@yzu.edu.cn.ORCID http://orcid.org/0000-0002-9924-6646
Xiaowen LiuAnimal Infectious Disease Laboratory, College of Veterinary Medicine, Yangzhou University, Yangzhou, 225000, China. xwliu@yzu.edu.cn.

Funding

Earmarked Fund for China Agriculture Research System CARS-40National Natural Science Foundation of China 31873021National Natural Science Foundation of China 32202767National Natural Science Foundation of China 32302840Priority Academic Program Development of Jiangsu Higher Education Institutions 111 Project D18007
6 · The paper itself

Abstract

The haemagglutinin-neuraminidase (HN) protein, a vital membrane glycoprotein, plays a pivotal role in the pathogenesis of Newcastle disease virus (NDV). Previously, we demonstrated that a mutation in the HN protein is essential for the enhanced virulence of JS/7/05/Ch, a velogenic variant NDV strain originating from the mesogenic vaccine strain Mukteswar. Here, we explored the effects of the HN protein during viral infection in vitro using three viruses: JS/7/05/Ch, Mukteswar, and an HN-replacement chimeric NDV, JS/MukHN. Through microscopic observation, CCK-8, and LDH release assays, we demonstrated that compared with Mukteswar and JS/MukHN, JS/7/05/Ch intensified the cellular damage and mortality attributed to the mutant HN protein. Furthermore, JS/7/05/Ch induced greater levels of apoptosis, as evidenced by the activation of caspase-3/8/9. Moreover, JS/7/05/Ch promoted autophagy, leading to increased autophagosome formation and autophagic flux. Subsequent pharmacological experiments revealed that inhibition of apoptosis and autophagy significantly impacted virus replication and cell viability in the JS/7/05/Ch-infected group, whereas less significant effects were observed in the other two infected groups. Notably, the mutant HN protein enhanced JS/7/05/Ch-induced apoptosis and autophagy by suppressing NF-κB activation, while it mitigated the effects of NF-κB on NDV infection. Overall, our study offers novel insights into the mechanisms underlying the increased virulence of NDV and serves as a reference for the development of vaccines.

Indexed as

ApoptosisHN ProteinNewcastle DiseaseNewcastle disease virusNF-kappa BAnimalsChick EmbryoChickensPoultry DiseasesHN ProteinNF-kappa Bhaemagglutinin–neuraminidaseNewcastle disease virusNF-κBprogrammed cell deathviral infection

Identifiers

PMID38715081
PMCPMC11077864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.